BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:20231102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Central Standard Time TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Central Daylight Time TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION: \;Introduction - Jessica Shore\, PhD\, RNClinical Trial in IPF at Roche/Genentech (Genentech) - Cindy Burg\, PharmD\, BCPSGB0139: Ga lectin-3 Inhibitor for IPF (Galecto Biotech APS) - Alison Mackinnon\, PhD DTEND:20211111T190000Z DTSTAMP:20240329T142501Z DTSTART:20211111T180000Z LOCATION: SEQUENCE:0 SUMMARY:Clinical Trials Innovation Series UID:RFCALITEM638473011014275443 X-ALT-DESC;FMTTYPE=text/html:
 \;